Functional condition of enzymative activity and cardiospecific markers in traumatic disease in patients with improved body mass index
Vol 82 No 1 (2019), Intensive therapy
Vol 82 No 1 (2019)

Functional condition of enzymative activity and cardiospecific markers in traumatic disease in patients with improved body mass index

Intensive therapy
https://doi.org/10.35339/ekm.2019.01.07
Published July 1, 2020
V.V. Kucheryavchenko
Kharkov National Medical University
https://orcid.org/0000-0001-9360-8258
Yu.V. Volkova
Kharkov National Medical University
https://orcid.org/0000-0002-6248-3576
K.Yu. Sharlai
Kharkov National Medical University
https://orcid.org/0000-0002-1930-8289
PDF (Українська)

Keywords

cardiospecific markers
traumatic disease
systemic multivariate analysis
increased body mass index
polytrauma

How to Cite

Kucheryavchenko, V., Volkova, Y., & Sharlai, K. (2020). Functional condition of enzymative activity and cardiospecific markers in traumatic disease in patients with improved body mass index. Experimental and Clinical Medicine, 82(1), 43-48. https://doi.org/10.35339/ekm.2019.01.07
ACM ACS APA ABNT Chicago Harvard IEEE MLA Turabian Vancouver

Download Citation

Endnote/Zotero/Mendeley (RIS) BibTeX

Abstract

The purpose of our work was to analyze the functional state of enzyme activity and cardiospecific markers in traumatic disease in patients with an increased body mass index using systemic multivariate analysis. Analysis of mathematical models of the state of enzymatic activity and cardiospecific markers in all groups of patients determined that the process under study is regular with periods of instability of the state of the cardiovascular system in response to the injuries received the more clearly the greater the patient's body mass index at the time of admission to the hospital.
https://doi.org/10.35339/ekm.2019.01.07
PDF (Українська)

References

Grunau B.E., Pourvali R., Wiens M.O., Levin A., Li J., Grafstein E., et al. (2014). Characteritics and thirty day out comes of emergency department patients with elevated creatinekinase. Acad Emerg Med., vol. 21 (6), pp. 631–636.

Matveeva S.A., Matveeva I.V. (2016). Laktatdegidrogenaza i glyukoza krovi: osobennosti vzaimosvyazey u muzhchin s ishemicheskoy boleznyu serdtsa i saharnyim diabetom 2 tipa [Lactate dehydrogenase and blood glucose: features of interconnections in men with coronary heart disease and type 2 diabetes]. Yevraziyskiy kardiologicheskiy zhurnal – Eurasian heart journal, vol. 2, pp. 102–103 [in Russian].

Chernyavska I.V. (2015). Profil chynnykiv ryzyku sertsevo-sudynnykh zakhvoryuvan pry ishemichniy khvorobi sertsya v osib iz normalnym i porushenym vuhlevodnym obminom [A profile of risk factors for cardiovascular diseases in coronary heart disease in individuals with normal and abnormal carbohydrate metabolism]. Mizhnarodnyy endokrynolohichnyy zhurnal – International Endocrinology Journal. vol. 8 (72), pp. 83–87 [in Ukrainian].

Parahonskiy A.P. (2015). Patogenez klinicheskih proyavleniy sindroma endogennoy intoksikatsii [Pathogenesis of clinical manifestations of endogenous intoxication syndrome]. Zametki uchenogo – Scientist notes, vol. 1, № 1-1 (1), pp. 188–195 [in Russian].

McCommis K. S., Chen Z., Fu X., McDonald W.G., Colca J.R., Kletzien R.F et al. (2015). Loss of mitochondrial pyruvate carrier 2 in the liver leads to defects in gluconeogenesis and compensation via pyruvate alanine cycling. CellMetab., vol. 22, pp. 682–694.

Han T.S., Lean M.Ej. (2016). A clinical perspective of obesity, metabolic syndrome and cardiovascular disease. Cardiovascular Disease, vol. 5, рр. 1–13.

HrustalYov V.V. (2015). Ispolzovanie aktivnosti laktatdegidrogenazyi v klinicheskoy diagnostike [Use of lactate dehydrogenase activity in clinical diagnosis]. Molodoy uchenyiy – Young scientist, vol. 7, pp. 40-42. URL https://moluch.ru/archive/87/17010/.